Key points
Acetylcholine receptors are aggregated in the central regions of intrafusal muscle fibres.
Single unit muscle spindle afferent responses from isolated mouse extensor digitorum longus muscle were recorded in the absence of fusimotor input to ramp and hold stretches as well as to sinusoidal vibrations in the presence and absence of the acetylcholine receptor blockers d‐tubocurarine and α‐bungarotoxin.
Proprioceptive afferent responses to both types of stretch were enhanced in the presence of either blocker.
Blocking acetylcholine uptake and vesicular acetylcholine release by hemicholinium‐3 also enhanced stretch‐evoked responses.
These results represent the first evidence that acetylcholine receptors negatively modulate muscle spindle responses to stretch.
The data support the hypothesis that the sensory nerve terminal is able to release vesicles to fine‐tune proprioceptive afferent sensitivity.
Abstract
Muscle spindles are complex stretch‐sensitive mechanoreceptors. They consist of specialized skeletal muscle fibres, called intrafusal fibres, which are innervated in the central (equatorial) region by afferent sensory axons and in both polar regions by efferent γ‐motoneurons. Previously it was shown that acetylcholine receptors (AChR) are concentrated in the equatorial region at the contact site between the sensory neuron and the intrafusal muscle fibre. To address the function of these AChRs, single unit sensory afferents were recorded from an isolated mouse extensor digitorum longus muscle in the absence of γ‐motoneuron activity. Specifically, we investigated the responses of individual sensory neurons to ramp‐and‐hold stretches and sinusoidal vibrations before and after the addition of the competitive and non‐competitive AChR blockers d‐tubocurarine and α‐bungarotoxin, respectively. The presence of either drug did not affect the resting action potential discharge frequency. However, the action potential frequencies in response to stretch were increased. In particular, frequencies of the dynamic peak and dynamic index to ramp‐and‐hold stretches were significantly higher in the presence of either drug. Treatment of muscle spindle afferents with the high‐affinity choline transporter antagonist hemicholinium‐3 similarly increased muscle spindle afferent firing frequencies during stretch. Moreover, the firing rate during sinusoidal vibration stimuli at low amplitudes was higher in the presence of α‐bungarotoxin compared to control spindles also indicating an increased sensitivity to stretch. Collectively these data suggest a modulation of the muscle spindle afferent response to stretch by AChRs in the central region of intrafusal fibres possibly fine‐tuning muscle spindle sensitivity.
Key points
Muscular dystrophy patients suffer from progressive degeneration of skeletal muscle fibres, sudden spontaneous falls, balance problems, as well as gait and posture abnormalities.
Dystrophin‐ and dysferlin‐deficient mice, models for different types of muscular dystrophy with different aetiology and molecular basis, were characterized to investigate if muscle spindle structure and function are impaired.
The number and morphology of muscle spindles were unaltered in both dystrophic mouse lines but muscle spindle resting discharge and their responses to stretch were altered.
In dystrophin‐deficient muscle spindles, the expression of the paralogue utrophin was substantially upregulated, potentially compensating for the dystrophin deficiency.
The results suggest that muscle spindles might contribute to the motor problems observed in patients with muscular dystrophy.
Abstract
Muscular dystrophies comprise a heterogeneous group of hereditary diseases characterized by progressive degeneration of extrafusal muscle fibres as well as unstable gait and frequent falls. To investigate if muscle spindle function is impaired, we analysed their number, morphology and function in wildtype mice and in murine model systems for two distinct types of muscular dystrophy with very different disease aetiology, i.e. dystrophin‐ and dysferlin‐deficient mice. The total number and the overall structure of muscle spindles in soleus muscles of both dystrophic mouse mutants appeared unchanged. Immunohistochemical analyses of wildtype muscle spindles revealed a concentration of dystrophin and β‐dystroglycan in intrafusal fibres outside the region of contact with the sensory neuron. While utrophin was absent from the central part of intrafusal fibres of wildtype mice, it was substantially upregulated in dystrophin‐deficient mice. Single‐unit extracellular recordings of sensory afferents from muscle spindles of the extensor digitorum longus muscle revealed that muscle spindles from both dystrophic mouse strains have an increased resting discharge and a higher action potential firing rate during sinusoidal vibrations, particularly at low frequencies. The response to ramp‐and‐hold stretches appeared unaltered compared to the respective wildtype mice. We observed no exacerbated functional changes in dystrophin and dysferlin double mutant mice compared to the single mutant animals. These results show alterations in muscle spindle afferent responses in both dystrophic mouse lines, which might cause an increased muscle tone, and might contribute to the unstable gait and frequent falls observed in patients with muscular dystrophy.
In humans up to 80% of the information received from the outside world is processed by the visual pathway. Therefore, understanding the molecular and cellular bases of the formation of the retinofugal projection has been in the focus of research during the last decades. Besides our interest in the development of the visual pathway per se this circuit is also an excellent model system to study axon guidance, midline crossing, and formation of topographic neuronal maps in general. The generation of genetic animal models as well as the design of in vitro loss- and gain-of-function paradigms have provided insight into transcriptional networks, identified signalling molecules, extracellular matrix components, morphogens, and activity patterns which are involved in the establishment of the visual pathway. To provide a picture as complete as possible, we will summarize molecular mechanisms involved in axon guidance and retinotopic mapping as well as neuronal activity shaping retinal and thalamocortical projections focusing on the mouse as a model system and highlight discoveries made in other organisms that contribute to our understanding.
In early development, an excess of neurons is generated, of which later about half will be lost by cell death due to a limited supply of trophic support by their respective target areas. However, some of the neurons die when their axons have not yet reached their target, thus suggesting that additional causes of developmental cell death exist. Semaphorin 3A (Sema3A), in addition to its function as a guidance cue and mediator of timing and fasciculation of motor and sensory axon outgrowth, can also induce death of sensory neurons in vitro. However, it is unknown whether Neuropilin-1 (Npn-1), its binding receptor in axon guidance, also mediates the death-inducing activity. We show here that abolished Sema3A-Npn-1 signaling does not influence the cell death patterns of motor or sensory neurons in mouse during the developmental wave of programmed cell death. The number of motor and sensory neurons was unchanged at embryonic day 15.5 when this wave is concluded. Interestingly, the defasciculation of early motor and sensory projections that is observed in the absence of Sema3A or Npn-1 persists to postnatal stages. Thus, Sema3A-Npn-1 signaling plays an important role in the guidance and fasciculation of motor and sensory axons but does not contribute to the developmental elimination of these neurons.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.